Cite
HARVARD Citation
Sato, K. et al. (2018). Corrigendum to "Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab" [Lung Cancer 115 (2018) 71–74]. Lung cancer. pp. 230-231. [Online].